Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 9.312E-09 | 2.028E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.021E-07 | 5.559E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.278E-06 | 5.567E-03 | CYP2C19, CYP2C9, CYP3A4, NPC1, NR0B1 |
MF | GO:0005215; transporter activity | GO:0005330; dopamine:sodium symporter activity | 1.929E-06 | 6.168E-03 | SLC6A2, SLC6A3 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 2.747E-06 | 7.477E-03 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 3.856E-06 | 8.396E-03 | CYP2C9, CYP3A4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.103E-03 | 7.070E-03 | CYP2C9; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.516E-06 | 5.304E-05 | CYP2C9; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.212E-03 | 7.070E-03 | CYP2C9; CYP3A4 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.526E-03 | 7.628E-03 | CYP2C9; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.131E-05 | 2.710E-04 | CYP2C9; CYP3A4; CYP2C19 |
hsa03013 | RNA transport_Homo sapiens_hsa03013 | 8.152E-03 | 3.170E-02 | SMN2; SMN1 |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 3.543E-03 | 1.550E-02 | CYP2C9; CYP2C19 |
hsa04976 | Bile secretion_Homo sapiens_hsa04976 | 2.323E-05 | 2.710E-04 | SLCO1B1; SLCO1B3; CYP3A4 |
hsa05204 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.579E-05 | 3.132E-04 | CYP2C9; CYP3A4; CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | NR3C1 |
C00-D49: Neoplasms | Neuroendocrine cancer | C7A | SLC6A2 |
C00-D49: Neoplasms | Neuroblastoma | C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7 | SLC6A2 |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A; NR3C1 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NR3C1 |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | NR3C1 |